Probiotics for treatment of acute childhood diarrhea

ISRCTN ISRCTN18444252
DOI https://doi.org/10.1186/ISRCTN18444252
Secondary identifying numbers N/A
Submission date
08/02/2018
Registration date
23/02/2018
Last edited
04/08/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
The aim of this study is to assess the effectiveness and safety of a combination of three probiotics, Bifidobacterium lactis Bi-07, Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM, added to rehydration therapy in the treatment of acute watery diarrhea in hospitalized children.

Who can participate?
Infants and children with mild to moderate acute diarrhea

What does the study involve?
Participants are randomly allocated to receive either conventional treatment for diarrhea or conventional treatment for diarrhea plus probiotics. The duration of diarrhea is measured.

What are the possible benefits and risks of participating?
The use of probiotics may shorten the duration of diarrhea and improve stool consistency. The potential risks include a minor allergy to the probiotics.

Where is the study run from?
Chengdu Women & Children’s Central Hospital (China)

When is the study starting and how long is it expected to run for?
November 2016 to September 2017

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Ke Chen

Contact information

Dr Ke Chen
Scientific

No. 1617, Riyue Avenue
Qingyang District
Chengdu
610031
China

Study information

Study designMulticenter randomized open-label parallel-group controlled clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleThree combination probiotics for treatment of acute childhood diarrhea: an open labelled, randomized controlled trial
Study objectivesTo assess the efficacy and safety of three combination probiotics as an adjunct to rehydration therapy in the treatment of hospitalized children because of acute watery diarrhea.
Ethics approval(s)The institutional ethics committee of Anhui Provincial Hospital, 13/12/2016
Health condition(s) or problem(s) studiedAcute childhood diarrhea
InterventionThe randomized sequence was generated by a person not directly involved in execution of the study. The RAND function of Excel (Microsoft, Redmond, WA, USA) was used to generate computer randomly permutated codes. Simple randomization was used.

All included eligible diarrheal children were randomized to either:
1. Intervention group (IG): The preparation of three combination probiotics containing three unique strains of bacteria, Bifidobacterium lactis Bi-07, Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM in addition to the standard management of diarrhea. The three combination probiotics was given as a single sachet containing more than 10 billion colony forming units (CFU) once a day from the beginning of the treatment for diarrhea until 7 days after the drug withdrawal
2. Control group (CG): No probiotic medication

Study children were managed according to the WHO guidelines which included oral rehydration therapy (ORT) with reduced osmolarity ORS and zinc (zinc sulphate dispersible tablets) 20 mg/day and continued feeding. Severe dehydration was managed with intravenous fluids (ringer lactate) as per WHO guidelines. For one single subject, the intervention duration is once the day from the beginning of the treatment for diarrhea until 7 days after drug withdrawal.
Intervention typeSupplement
Primary outcome measureDuration of diarrhea [time in hours from enrolment to the last abnormal (loose or liquid) stool], measured using an appropriate CRF every day during the intervention
Secondary outcome measuresNumber of loose stools per day during the entire episode, measured using an appropriate CRF every day during the intervention
Overall study start date01/11/2016
Completion date30/09/2017

Eligibility

Participant type(s)Patient
Age groupChild
SexBoth
Target number of participants216
Total final enrolment194
Key inclusion criteriaInfants and children with an episode of mild to moderate acute diarrhea (>4 (semi)watery stools/day according to Bristol criteria (Bristol criteria ≥6)) lasting more than 12 h and less than 72 h, requiring hospitalization
Key exclusion criteria1. Subjects with clinical features of hypovolemic shock and/or necessitating admission at the intensive care unit
2. Taking immunosuppressive therapy
3. Known immunodeficiency disorder
4. Pancreatic dysfunction
5. Bloody diarrhea
6. Chronic gastrointestinal disease
7. Short bowel syndrome
8. Bilious or bloody vomitus
9. Probiotics 1 month before admission
10. Severe malnutrition
Date of first enrolment01/05/2017
Date of final enrolment25/09/2017

Locations

Countries of recruitment

  • China

Study participating centre

Chengdu Women & Children’s Central Hospital
No. 1617
Riyue Avenue
Qingyang District
Chengdu
610031
China

Sponsor information

Infinitus (China) Company Ltd
Industry

No.12, Jiangxi Road
Zhujiang New City
Tianhe District
Guangzhou
510091
China

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date30/09/2018
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer reviewed journal and presentations at professional conferences.
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Dr Ke Chen.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 12/08/2020 04/08/2020 Yes No

Editorial Notes

04/08/2020: The following changes have been made:
1. Publication reference added.
2. The total final enrolment number has been added from the reference.